Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03325855 · ClinicalTrials.gov registry record
Fecal Microbiota Transplant National Registry
A clinical trial of Gut Microbiome and Clostridium Difficile Infection, sponsored by American Gastroenterological Association.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 20
- Study locations
NCT03325855: Recruiting study of Gut Microbiome and Clostridium Difficile Infection, sponsored by American Gastroenterological Association.
NCT03325855 is a study of Gut Microbiome and Clostridium Difficile Infection that is actively recruiting participants, run by American Gastroenterological Association. The registered enrollment target is 4,000 participants, above the 86-participant average among 22 other Gut Microbiome trials with a reported enrollment target (4551% higher). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03325855, a study of Gut Microbiome and Clostridium Difficile Infection, is actively recruiting participants, sponsored by American Gastroenterological Association.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness
Primary Outcome
Adverse events to be monitored include surgeries, infection, hospitalization, other life-threatening events, death and newly diagnosed diseases.
Conditions Studied
Interventions
- OTHER None - Observational
Study Locations (20)
California
- Children's Hospital of Los Angeles - Los Angeles
- University of California - Los Angeles
- Stanford University - Redwood City
- Sutter Roseville Medical Center - Roseville
- University of California San Francisco - San Francisco
- Ventura Clinical Trials - Ventura
Illinois
- The University of Chicago - Chicago
- University of Chicago School of Medicine - Chicago
- NorthShore University Health System - Evanston
- Loyola University Medical Center - Maywood
- Loyola University of Chicago/ Loyola University Medical Center - Maywood
- Carle Foundation Hospital - Urbana
Florida
- Best Quality Research, Inc. - Hialeah
- University of Miami, Miller School of Medicine - Miami
- GI Pros - Naples
Arizona
- Phoenix Children's Hospital - Phoenix
Connecticut
- Yale New Haven Hospital - Hamden
District of Columbia
- MedStar Georgetown University Hospital - Georgetown
Georgia
- Emory University School of Medicine - Atlanta
Indiana
- Indiana University School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2027-08 |
What NCT03325855 shows while recruiting
NCT03325855 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 86-participant average among 22 other Gut Microbiome trials with a reported enrollment target (4551% higher).
The record links to 3 conditions, with Gut Microbiome appearing as the primary indexed condition, and to 1 intervention - of which None - Observational is the first listed.
NCT03325855 names 20 study sites across 8 states, led by California, Illinois, Florida.
Frequently Asked Questions
What is clinical trial NCT03325855 about?
NCT03325855 is a clinical study titled "Fecal Microbiota Transplant National Registry". A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness
What is the current status of trial NCT03325855?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2017-09-20. Estimated completion is 2027-08.
What conditions does trial NCT03325855 study?
This clinical trial studies the following conditions: Gut Microbiome, Clostridium Difficile Infection, Fecal Microbiota Transplantation.
What interventions are being tested in trial NCT03325855?
The interventions under investigation include: None - Observational (OTHER).
Who is sponsoring clinical trial NCT03325855?
This trial is sponsored by American Gastroenterological Association, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03325855 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gut Microbiome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03325855's enrollment target sits among peer trials
4,000 1st of 22 higher than 22 of 22 other Gut Microbiome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gut Microbiome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Flourish: Exploring the Early Infant Gut Microbiome
RECRUITING · NA
-
The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
RECRUITING · NA
-
Enhanced Nutritional Optimization in LVAD Trial
RECRUITING · NA
-
Feasibility and Potential Efficacy of Herbs and Spices for Improving Dietary Quality in College Students: A Pilot Study
RECRUITING · NA
-
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
RECRUITING · NA
-
Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI